Impact of COVID-19 and Associated Preventive Measures on Cardiometabolic Risk Factors in South Korea: An Observational Study

Minji Sohn,Bo Kyung Koo,Soo Lim,Ho Il Yoon,Kyoung-Ho Song,Eu Suk Kim,Hong Bin Kim
DOI: https://doi.org/10.21203/rs.3.rs-127499/v1
2020-12-17
Abstract:Abstract Background: During the COVID-19 pandemic, people have been required to follow preventive measures such as social distancing or staying at home, which can lead to an unhealthy lifestyle. We investigated the effect of these preventive measures on metabolic parameters in individuals with cardiometabolic risk factors. Methods: Using data for patients who visited a tertiary hospital in South Korea at least twice a year for the past 4 years, changes in clinical and biochemical data from the COVID-19 pandemic (2019–2020) were compared with changes in the same data at the same annual time points during the three previous seasons of 2016–2019. Results: Among 7,094 patients, data for 1,485 were included. Systolic blood pressure increased by 2.6 ± 18.2 mmHg in the COVID-19 pandemic period compared with the 2018–2019, 2017–2018, and 2016–2017 seasons: –1.4 ± 16.5 mmHg, –2.8 ± 14.3 mmHg, and –0.7 ± 14.3 mmHg, respectively; all p < 0.05. The body mass index increased by 0.09 ± 1.16 kg/m 2 in the 2019–2020 pandemic season whereas it changed by –0.39 ± 3.03 kg/m 2 in 2018–2019 and by –0.34 ± 2.18 kg/m 2 in 2017–2018 (both p <0.05). Total cholesterol, triglycerides, high-density lipoprotein-cholesterol, and low-density lipoprotein-cholesterol levels worsened in the pandemic season compared with the previous three. Fasting glucose and glycated hemoglobin levels also showed increasing tendencies during the pandemic, but without significance. During the COVID-19 pandemic, the number of patients whose metabolic syndrome worsened increased significantly by 21% compared with the 2018–2019 season. The 10-year coronary heart disease risk calculated using the Framingham risk score also increased significantly. Conclusions: Comorbidity and mortality arising from cardiometabolic disorders as collateral damage during COVID-19 infections and preventive procedures could have major impacts on human health in the future. Nationwide strategies to reverse the aggravation of cardiometabolic health during a pandemic should be implemented in countries attempting to cope with it.
What problem does this paper attempt to address?